Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports on fecal microbiota transplantation for active ulcerative colitis across Phase 1 and Phase 2, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Alberta | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED